APA (7th ed.) Citation

Dreger, P., Döhner, H., Ritgen, M., Böttcher, S., Busch, R., Dietrich, S., . . . Stilgenbauer, S. (2010). Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: Long-term clinical and MRD results of the German CLL Study Group CLL3X trial. Blood, 116(14), . https://doi.org/10.1182/blood-2010-03-275420

Chicago Style (17th ed.) Citation

Dreger, Peter, et al. "Allogeneic Stem Cell Transplantation Provides Durable Disease Control in Poor-risk Chronic Lymphocytic Leukemia: Long-term Clinical and MRD Results of the German CLL Study Group CLL3X Trial." Blood 116, no. 14 (2010). https://doi.org/10.1182/blood-2010-03-275420.

MLA (9th ed.) Citation

Dreger, Peter, et al. "Allogeneic Stem Cell Transplantation Provides Durable Disease Control in Poor-risk Chronic Lymphocytic Leukemia: Long-term Clinical and MRD Results of the German CLL Study Group CLL3X Trial." Blood, vol. 116, no. 14, 2010, https://doi.org/10.1182/blood-2010-03-275420.